Halozyme Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2012 | 112.7M |
| FY2013 | 114.5M |
| FY2014 | 125.7M |
| FY2015 | 126.7M |
| FY2016 | 128.0M |
| FY2017 | 139.1M |
| FY2018 | 143.6M |
| FY2019 | 144.3M |
| FY2020 | 141.5M |
| FY2021 | 146.8M |
| FY2022 | 140.6M |
| FY2023 | 134.2M |
| FY2024 | 129.4M |
| FY2025 | 123.9M |
| FY2026 | 118.0M |